<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02698631</url>
  </required_header>
  <id_info>
    <org_study_id>ALICIA-FA</org_study_id>
    <nct_id>NCT02698631</nct_id>
  </id_info>
  <brief_title>Isolation of Pulmonary Veins With the Aid of Magnetic Resonance Imaging</brief_title>
  <acronym>ALICIA</acronym>
  <official_title>Isolation of Pulmonary Veins With the Aid of Magnetic Resonance Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Clinic of Barcelona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut d'Investigacions Biomèdiques August Pi i Sunyer</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Barcelona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Clinic of Barcelona</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The ALICIA-FA study will elucidate whether targeting atrial myocardial fibrosis identified by
      late gadolinium-enhanced magnetic resonance imaging (LGE-MRI) improves atrial fibrillation
      (AF) ablation outcomes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Atrial fibrosis is a hallmark of the AF substrate. An accurate identification and
      localization of myocardial fibrosis areas prior to an ablation procedure by means of LGE-MRI
      might help to target atrial areas harboring AF, thereby improving ablation outcomes and
      reducing AF recurrences.

      In order to test this hypothesis, we will conduct a randomized study comparing the isolation
      of pulmonary veins without fibrosis imaging (conventional ablation procedure) vs. isolation
      of the pulmonary veins and pathological (fibrotic) tissue with the aid of LGE-MRI. Fibrotic
      tissue patches will be encircled and isolated in all patients in the active arm; furthermore,
      LGE-MRI will be used to identify, locate and guide ablation catheter to anatomical gaps
      surrounding pulmonary veins in re-do procedures.

      Eventually, we will identify an optimized ablation strategy in patients undergoing AF
      radiofrequency ablation on the basis of left atrium (LA) fibrosis characterization.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Freedom from atrial arrhythmias, lasting more than 30 sec.</measure>
    <time_frame>1 year</time_frame>
    <description>Recurrence is defined as any documented episode of AF/atrial tachycardia lasting more than 30 seconds, after a blanking period of 3 months.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total time of radiofrequency application</measure>
    <time_frame>During procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total X-ray time</measure>
    <time_frame>During procedure</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">154</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Conventional AF ablation.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A standard radiofrequency AF ablation procedure will be carried out without LGE information.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LGE-MRI guided AF ablation.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fibrosis information obtained from post-processed LGE-MRI will be used to guide AF ablation procedures.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional AF ablation</intervention_name>
    <description>Conventional AF ablation will be carried out according to the standard procedure. Atrial anatomical MRI information will be integrated into the navigation system. Ablation procedure will be carried out with a Smart Touch® catheter (temperature 45 °C, 40W or 30W for anterior or posterior wall, respectively).
Both in first and re-do procedures, procedure endpoint will be electrical isolation of all pulmonary veins.</description>
    <arm_group_label>Conventional AF ablation.</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>LGE-MRI guided AF ablation</intervention_name>
    <description>Post-processed LGE-MRI will be used to identify left atrial fibrotic patches and lesions surrounding pulmonary veins (re-do procedures). Both MRI atrial anatomical and fibrosis information will be integrated into the navigation system. Ablation procedures will be carried out with a SmartTouch® catheter (temperature 45°C, 40W or 30W for anterior or posterior wall, respectively).
Procedural end-point for first ablation procedures will be isolation of all pulmonary veins, and encirclement and isolation of all atrial fibrotic areas.
In re-do procedures, all left atrial fibrosis patches will be encircled and isolated and, for electrically non-isolated pulmonary veins, all anatomical gaps in lesions surrounding pulmonary veins (as identified in LGE-MRI) will be closed.</description>
    <arm_group_label>LGE-MRI guided AF ablation.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing a first or subsequent ablation procedure.

          -  Pre-procedural 3 Tesla LGE-MRI.

          -  Referred for radiofrequency ablation of pulmonary veins (paroxysmal, persistent or
             long-standing AF).

          -  Signed informed consent.

        Exclusion Criteria:

          -  Claustrophobia.

          -  Refusal to participate in the study.

          -  Presence of atrial thrombus.

          -  LA anteroposterior diameter &gt;55 mm.

          -  Major renal impairment.

          -  Contrast allergy.

          -  Pregnancy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lluís Mont, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Clínic de Barcelona</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lluís Mont, MD PhD</last_name>
    <email>lmont@clinic.ub.es</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Universitari Germans Trias i Pujol</name>
      <address>
        <city>Badalona</city>
        <state>Barcelona</state>
        <zip>08916</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Felipe Bisbal, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospial Clinic of Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lluís Mont, MD PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 4, 2016</study_first_submitted>
  <study_first_submitted_qc>February 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 4, 2016</study_first_posted>
  <last_update_submitted>August 9, 2017</last_update_submitted>
  <last_update_submitted_qc>August 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Clinic of Barcelona</investigator_affiliation>
    <investigator_full_name>Josep Lluis Mont Girbau</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <keyword>Catheter Ablation</keyword>
  <keyword>Radiofrequency</keyword>
  <keyword>Fibrosis</keyword>
  <keyword>Late-gadolinium enhanced MRI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

